Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Cellular self-digestion process plays role in development of autoimmune diseases

Autophagy allows cells to degrade and recycle their cellular components. Researchers at UZH have now demonstrated that the autophagy machinery in certain immune cells leads to the immune system attacking the central nervous system.

13 Dec 2017

Study reveals how the body clock and time of day may influence autoimmune conditions

Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.

12 Dec 2017

Taurine could boost effectiveness of existing multiple sclerosis therapies

New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies.

8 Dec 2017

Healthy diet may be linked to less disability, fewer symptoms for people with MS

For people with multiple sclerosis (MS), eating a healthy diet of fruits, vegetables and whole grains may be linked to having less disability and fewer symptoms than people whose diet is less healthy, according to a study published in the December 6, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Dec 2017

Scientists identifies new genetic changes that increase risk of developing Hodgkin lymphoma

People who inherit genetic changes which alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, a major new study reports.

1 Dec 2017

Blood test could provide low-cost alternative to MRI for monitoring disease activity in MS

A blood test to monitor a nerve protein in the blood of people with multiple sclerosis (MS) may help predict whether disease activity is flaring up, according to a study published in the November 29, 2017, online issue of Neurology Neuroimmunology and Neuroinflammation, an official journal of the American Academy of Neurology.

30 Nov 2017

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease (IDD) but may be unsure of the exact disorder.

28 Nov 2017

New discovery could speed up production of cells for studying diseases

Scientists have made a key discovery that could speed up the production of cells in the lab for studying diseases such as multiple sclerosis and Parkinson's disease.

28 Nov 2017

Parents are not liable for medical debts of adult children on shared insurance

Are parents responsible for adult children's medical debts? Should people squeeze in appointments and expensive procedures before year's end because of changes that might come with the GOP tax bill? Should consumers pay a broker to help them enroll in a plan? I answer these questions from readers this week.

28 Nov 2017

MS patients who adhere to medication schedules have better physical outcomes

Researchers examined the insurance claims and medical records of 681 patients with multiple sclerosis (MS) and found those who adhered to medication schedules had significantly better physical outcomes than patients who did not, although the total overall costs for their care were higher.

28 Nov 2017

Multiple sclerosis drug can beat obstinate bacteria

Encountering bacteria with innocent names such as Pseudomonas aeruginosa and Enterobacteriaceae can lead to hospitalization and - in a worst-case scenario - can also be life-threatening. The bacteria, which cause infections such as pneumonia, frequently develop multi-resistance towards classic antibiotics.

22 Nov 2017

Researchers uncover how rogue immune cells gain access to neurons in multiple sclerosis

Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

21 Nov 2017

Gut bacteria at young age can contribute to MS onset and progression, study suggests

Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to Multiple sclerosis (MS) disease onset and progression.

21 Nov 2017

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

The food allergy, which is related to birch pollen, is a very common attendant phenomenon associated with birch pollen allergy - indeed around 70% of those with a birch pollen allergy are also allergic to apples. That amounts to around 280,000 people in Austria.

20 Nov 2017

Gut bacteria at young age can contribute to MS disease onset and progression, study suggests

Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to Multiple sclerosis (MS) disease onset and progression.

17 Nov 2017

Virtual reality training may be effective alternative to standard therapy after stroke

Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular therapy, according to a study published in the November 15, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Nov 2017

Parkinson's disease will soon become looming pandemic, research reveals

New research shows that the number of people with Parkinson's disease will soon grow to pandemic proportions. In a commentary appearing today in the journal JAMA Neurology, University of Rochester Medical Center neurologist Ray Dorsey, M.D. and Bastiaan Bloem, M.D., Ph.D., with Radboud University Medical Center in the Netherlands, argue that the medical community must be mobilized to respond to this impending public health threat.

13 Nov 2017

Air pollution may exacerbate osteoporosis

Based on a study of nine million people, researchers at Columbia University's Mailman School of Public Health People report that people living amidst high levels of air pollution are more likely to suffer bone fractures from osteoporosis than those living in areas with less pollution.

10 Nov 2017

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod.

10 Nov 2017

Early intervention may be crucial to successful treatment of Friedreich's ataxia

New research published today in Disease Models & Mechanisms indicates that early intervention should be a key target in the development of new therapeutics for Friedreich's ataxia, as current treatments may be administered too late to target the disease effectively.

8 Nov 2017

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Cellular self-digestion process plays role in development of autoimmune diseases

Study reveals how the body clock and time of day may influence autoimmune conditions

Taurine could boost effectiveness of existing multiple sclerosis therapies

Healthy diet may be linked to less disability, fewer symptoms for people with MS

Scientists identifies new genetic changes that increase risk of developing Hodgkin lymphoma

Blood test could provide low-cost alternative to MRI for monitoring disease activity in MS

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

New discovery could speed up production of cells for studying diseases

Parents are not liable for medical debts of adult children on shared insurance

MS patients who adhere to medication schedules have better physical outcomes

Multiple sclerosis drug can beat obstinate bacteria

Researchers uncover how rogue immune cells gain access to neurons in multiple sclerosis

Gut bacteria at young age can contribute to MS onset and progression, study suggests

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

Gut bacteria at young age can contribute to MS disease onset and progression, study suggests

Virtual reality training may be effective alternative to standard therapy after stroke

Parkinson's disease will soon become looming pandemic, research reveals

Air pollution may exacerbate osteoporosis

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

Early intervention may be crucial to successful treatment of Friedreich's ataxia

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in